In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras -Mutant Lung Adenocarcinoma

Fei Li

China Mobile (China)

Qingyuan Huang

Shanghai Medical College of Fudan University

Troy A. Luster

Dana-Farber Cancer Institute

Cancer Discovery

Harvard University

Brigham and Women's Hospital

New York University